Brief: Allovir Inc- On January 1, Approved Reduction Of Its Workforce By Approximately 95%
Jan 4 (Reuters) - Allovir Inc ALVR.O :
* ALLOVIR INC- ON JANUARY 1, 2024, BOARD OF DIRECTORS OF
ALLOVIR,
INC. ("ALLOVIR") APPROVED A REDUCTION ITS WORKFORCE BY
APPROXIMATELY 95%
* ALLOVIR INC - WORKFORCE REDUCTION WILL TAKE PLACE
PRIMARILY
DURING Q1 OF 2024 AND EXPECTS TO BE SUBSTANTIALLY COMPLETED BY
APRIL 15, 2024
* ALLOVIR INC- ALLOVIR EXPECTS TO INCUR PERSONNEL-RELATED
RESTRUCTURING CHARGES OF APPROXIMATELY $13 MILLION
Source text for Eikon: ID:
Further company coverage: ALVR.O
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million